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Introduction
In the first Part of this article (see p. 177) an automated
procedure for the analysis of amino-acids in human
physiological fluids, using pre-column derivatization
with o-pththalaldehyde/2-mercaptoethanol (OPA/
MCE) and high pressure liquid chromatography
(HPLC), was described. This method utilizes dialysis to
remove high molecular weight components that can
poison chromatography columns, and permits both
complex and concentrated biological samples to be
sampled directly. The intense fluorescence ofOPA/MCE
derivatives of amino-acids compensates for the poor
efficiency of dialysis but limits the application of this
sample preparation technique to assays using sensitive
detection or those where analytes are present at a high
concentration. Trace enrichment has been used previ-
ously for concentrating samples and the incorporation
of such a device in the dialyser recipient stream should
theoretically overcome this limitation and increase the
range of HPLC methods to which deproteinization by
dialysis may be applied.
This paper reports on the development of an automated
sample preparation system incorporating dialysis and
trace enrichment for the treatment of biological fluids
prior to HPLC [2]. An examination of the system’s
performance is d.escribed using the analysis oftherapeutic
concentrations of a drug, phenobarbitone, in human
serum.
Materials and methods
Instrumentation
An isocratic HPLC system was used. This consisted of a
Gilson 302 pump and a Gilson Holochrome UV detector
(Gilson International, Vitliers-le-Bel, France) set at a
wavelength of 225 nm. The loop on the Rheodyne 7010
valve was replaced by a specially designed traced
enrichment cartridge (TEC) (see figure 1), described
below. The analytical column used was a 100 mm 4"6
mm i.d. column packed with Zorbax ODS (Du Pont Ltd,
Hitchin, UK); for some experiments this was fitted with a
guard column packed with CO PELL ODS of25-37m
diameter (Whatman Ltd, Maidstone, UK).
Dialysis and TEC system
The automated sampling system comprised a modified
auto-analyser (AA) sampler (as described in Part I
[p. 177], but fitted with an ordinary sample probe), a 6 in
dialyser block and cuprophan membrane, and an AA1
peristaltic pump (all from Technicon, Basingstoke, UK).
A Gilson 302 HPLC pump fitted with a 5 ml liquid head
was included to pump the dialyser recipient stream
through the TEC on the Rheodyne valve. This pump was
modified by placing a 5V miniature relay across the flow
control switch to allow automatic switching. All the timed
operations of these device were controlled by a SP4100
integrator (Spectra Physics Ltd, St. Albans, UK) via the
external event switches and relays, see Part !. The design
of the TEC is shown in figure 1. Hypersil 5 tm ODS
(Shandon Southern Products Ltd, Runcorn, UK), was
loaded into the retaining washer. This was carried out by
pipetting a ml slurry ofHypersil (20 mg/ml in acetone)
into a 4"6 mm o.d. polypropylene tube compressed onto
the washer and applying a vacuum to the outlet of the
cartridge.
Reagents
The drugs phenobarbitone and hexobarbitone were
obtained from Sigma London Chemical Company Ltd,
Poole, UK. Acetonitrile Far UV grade from Fisons
Scientific Apparatus, Loughborough, UK. Unless other-
wise stated, all chemicals were analytical grade and were
supplied by BDH Chemicals Ltd, Poole, UK. Water
purified through activated carbon and an ion exchange
resin (Spectrum C system, Elga Ltd, High Wycombe,
UK) was used for all reagent preparations.
Stock phenobarbitone solution
600 mg of phenobarbitone was dissolved in 100 ml
methanol.
Internal standard solution
1000 mg of hexobarbitone was dissolved in 100 ml of
methanol.
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Elution solvent
The HPLC solvents were filtered through a 0"45 tm pore
size filter (Anachem Ltd, Luton, UK) and degassed with
helium before use. The elution solvent was aceto-
nitrile:water (30:70 by volume) at a flow rate of 2"0
ml/min.
Procedures
Dialyser and TEC system
The configuration of the system is shown in figure 2. The
timing diagram for treating one sample operation is
shown in figure 3; the system operates as follows: serum
specimens are loaded into sample cups and placed on the
sampler, the integrator activated the sampler to intro-
duce the probe into the sample. The AA pump is
energized and the sample is aspirated into the dialyser
block until the donor channel is completely filled. The
sample pump is switched off and the probe rettlrned to
the wash position on the sampler. The Gilson 302 pump is
energized and water is aspirated through the recipient
side of the dialyser and into the TEC. The injection valve
is then switched to the inject position. The chromato-
graphy solvent elutes the analytes from the TEC onto the
analytical column and the integration of the chromato-
graphy is initiated. The sample pump is energized, and,
with the TEC pump still running, the system is washed
out with water. The injection valve is switched to the load
position and the TEC re-equilibrated with water via the
TEC pump. After re-equilibration of the TEC, both
pumps are switched off. At the end of the chromato-
graphy and report, the cycle is repeated.
D
G
Figure 1. Sectional view ofthe TEC; the arrow indicates direction
ofsolventflow; A, halfofa 1/16 in union with its centre hexagonal
5/16 inflats reduced in size; B, machined 1/16 in nut; C, inverted
female endfitting, reduced in depth; D, 35 lam top mesh (1/4 in);
E, teflon washers; F, 1 lm bottom mesh (1/4 in); G, retaining
washer for trace enrichment material. The flats remaining on A
pass through the 1/4 in hole in the 1/4 in nut, which, when
tightened, bear on the remaining 5/16 in flats on B.
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Figure 2. Schematic diagram of the dialysis/TEC system. Flow
rate ofpump tube 1 0.80 ml/min.
Quantitation
The phenobarbitone peak was identified by its relative
retention time to the reference peak and the peak areas
.determined by the SP4100 integrator.
System design and validation
TEC design
A diagram of the TEC is shown in figure 1. By using
different thickness stainless-steel washers, the amount of
hypersil packed into the cartridge can be varied. Ideally,
the minimum quantity ofpacking material is required to
minimize the pressure drop across the TEC and to reduce
the re-equilibration time of the TEC with water after its
exposure to the chromatographic solvent. However, the
volume of aqueous dialysate passed through the TEC is
dependent on the TEC capacity (K’) for the analyte. This
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Figure 3. Timing diagram of the sample preparation system.
was experimentally determined by replacing the analy-
tical HPLC column with the TEC and injecting a
concentrated solution of phenobarbitone in water via the
injection valve fitted with a 20 tl loop. Water, as the
mobile phase, was passed through the TEC at a known
flow rate (1-0 ml/min) and the retained phenobarbitone
eluted. The volume of water required to elute the
phenobarbitone was thus estimated. With the TEC and
dialyser repositioned in the system, this volume was not
exceeded. The amount of packing material in the TEC
was large enough to give a K’ for phenobarbitone of 7 ml.
This was sufficient to obtain effective dialysis times and
flow rates.
Process times
Like the system described in Part I, the process times
were dependent on the dialyser size, volumes of connect-
ing tubes, and pump tube flow rates. The time taken to
aspirate sample into the dialyser was determined as in
Part I and used identical pump and connecting tube sizes.
However, in this procedure the sample was then held in
the donor side of the dialyser block during trace
enrichment and the TEC pump times have to be
considered. The time taken for trace enrichment depends
on both the K’ of the analyte and its concentration in the
sample to be assayed. In this assay the time taken for
trace enrichment was 2 min. This gave sufficient sensitiv-
ity for the detection of therapeutic concentrations of
phenobarbitone at 0"05 AUFS on the UV detector. The
flow rate of the recipient stream through the dialyser also
depends on the dead volume of the system. If the dead
volume is large, high flow rates are required to minimize
both trace enrichment and wash cycle times. With the
Gilson 302 pump, a flow rate of 2"5 ml/min was
employed. This was sufficient to limit the wash cycle time
to min.
Precision of the system
Figure 4 shows the chromatograms obtained with the
treated serum samples using the system described. The
performance of the system was examined by estimating
the within-run assay variance, with and without reference
to the internal standard. 0"5 ml of stock phenobarbitone
and 0"5 ml of stock hexobarbitone solution was diluted to
100 ml with pooled human serum. This provided a serum
phenobarbitone concentration of 30 mg/1, which was
within the recognized therapeutic range of 15-40 mg/1 [3]
for this drug. Thirty samples of the pooled supplemented
serum were analysed through the dialysis, TEC system.
The coefficient ofvariation with and without reference to
hexobarbitone was 1.5% and 1.4% respectively. Carry-
over between samples was determined by sampling a
serum sample (supplemented with phenobarbitone and
hexobarbitone), followed by a water sample. No carry-
over could be detected. The procedure was found to be
linear up to 100 mg/1 of phenobarbitone in serum.
Efficiency of the system
The efficiency of the system was determined by substitu-
ting the dialysis/TEC components with a standard 20 tl
loop on the 7010 Rheodyne valve and injecting known
quantities ofphenobarbitone and hexobarbitone onto the
HPLC column. The peak areas obtained were compared
with those obtained using the dialysis/TEC system
described. The recovery of the analytes were calculated
on the basis ofthe volume ofthe donor side ofthe dialyser
and found to be 28 and 32% for phenobarbitone and
hexobarbitone respectively.
Discussion
The automatic sequential, trace enrichment of dialysates
(ASTED) suggests that this type of process for the
autonatic preparation of complex biological material
prior to HPLC may offer some advantages over conven-
tional procedures.
One ofthe principal problems encountered with assays of
biological material using HPLC is the clean-up tech-
niques that are required. Manually these are usually
performed by protein precipitation [4] and liquid/liquid
extractions [5]. Even the interfering compounds can
affect the chromatography [6]. With dialysis/TEC sam-
ple preparation, the chromatograms appeared free from
interfering peaks (figure 4). This resulted in an extended
life of the TEC because it can be regenerated for many
cycles (over 250 injections have been made with one
TEC) and the life ofthe analytical column was prolonged.
Furthermore, guardcolumns were found to be unneces-
sary, so efficiencies of small particle columns (<5 m)
were not reduced.
Although dialysis is not regarded as an efficient process
analyte recoveries of greater than 50% from biological
material should be possible with future modifications.
This is because the system approaches exhaustive dialysis
by holding the donor side in a stop-flow state and moving
the recipient stream in a continuous mode across the
membrane and into the TEC. However, exhaustive
dialysis is unrealistic because the dialysis rate will
’decrease as the sample analyte concentration decreases
and thus the time taken for analysis would be very long.
In the case of phenobarbitone, total exhaustion of the
analyte from the donor to the recipient stream is also
impracticable because (1) the total volume of the
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This report describes a new approach to sample prepara-
tion prior to HPLC. Preliminary results using the system
to estimate phenobarbitone in human serum demonstrate
a promising potential for this technique. The procedure
may also be applicable to a wide range of analytes in
complex material since there are also a number of
variables that can be altered within the system. For
instance: the material used in the TEC, the nature of the
recipient stream, the molecular weight cut off of the
dialyser membrane, the size of the dialyser block and the
process times may all be changed to suit different
analyses.
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